Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07114653

The Role of POLE Mutation in High Risk Endometrial Cancer.

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The actual role of POLE mutations in high-risk endometrial cancer is undetermined. The main question it aims to answer is: What is the prevalence of POLE mutations in high-risk endometrial cancer case? What is the impact of POLE mutations in real world high-risk endometrial cancer case?

Detailed description

All high-risk recurrent endometrial cancer cases who were treated in a tertiary referral center will be analyzed and subjected to POLE mutation analysis. In addition, survival analysis will be used to analyze the role of POLE mutations in women with high-risk endometrial cancer. We can answers the following. 1. What is the prevalence of POLE mutations in women with high-risk endometrial cancer? 2. What is the role of POLE mutations in real world high-risk endometrial cancer?

Conditions

Timeline

Start date
2025-09-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-08-11
Last updated
2025-08-11

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07114653. Inclusion in this directory is not an endorsement.